Wedbush Maintains Underperform on Praxis Precision Medicine, Lowers Price Target to $162
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and lowers the price target from $166 to $162.
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and lowers the price target from $166 to $162.